Skip to main content
. 2013 Aug 30;2013(8):CD001245. doi: 10.1002/14651858.CD001245.pub2

1.1. Analysis.

Comparison 1 Antifibrinolytic treatment versus control treatment with or without placebo, Outcome 1 Poor outcome (death, vegetative or severe disability on Glasgow Outcome Scale at end of follow‐up): open versus blind studies.